Cancer Drug Stunts Child's Growth PermanentlyPublished - Nov 18, 2011
Chronic Myelogenous Leukemia (CML) is a type of Leukemia (blood cancer) for which the drug Gleevec is commonly used. In children this drug appears to stop a child’s growth permanently. This was reported in The Journal of Pediatrics.
It is believed this happens mostly to children given the drug prior to puberty. If used before puberty, generally age 12, growth is halted but it is hoped the child will “catch up” after puberty.
CML is a Cancer that starts in the blood forming cells of the bone marrow. It affects 4600 people a year and many are adults. Preventing growth in adults is obviously not the concern it is in children.